Roth Capital upgrades Kroger to Buy, sees performance gap closing
Get Alerts KR Hot Sheet
Join SI Premium – FREE
Investing.com -- Roth Capital Partners upgraded Kroger to Buy from Neutral in a note on Wednesday, citing consistent performance improvements and a valuation that continues to trail competitors.
The firm also raised its price target for the stock to $75 from $66.
“Kroger, again, surpassed expectations, with strong ID sales and SG&A expense control/leverage,” Roth Capital wrote. “FY’25 returns to profit growth, and ID Sales have accelerated, narrowing the gap to leading competitors. Despite this, Kroger’s valuation (~7.6x EV/NTM EBITDA) has lagged peers.”
The analysts pointed to multiple performance drivers, including “strong alternative profit streams (~$1.5bn); margin accretive private brands; supply chain savings; and pharmacy gains.”
Same-store sales have rebounded steadily, improving from a trough of -0.8% in 2023 to +3.4% in 2Q25. Roth Capital expects ID sales ex-fuel to hold at 3.4% in both 3Q and 4Q, above consensus forecasts of around 3%.
The firm highlighted the resilience of the food-at-home channel, which benefits from consumer belt-tightening.
“In times of consumer stress, Food-at-Home enjoys a channel shift away from restaurants,” the note said. With CPI for food at home rising 2.7% year-on-year in August, the highest since August 2023, Roth Capital sees tailwinds for profitability.
Valuation remains a key theme. “Walmart gets credit for strong brick&mortar performance and digital ecosystem building, but investors have neglected the similar progress at Kroger,” Roth Capital wrote.
They note that Kroger’s e-commerce growth of 16% and alternative profit EBIT of $1.5 billion compare favorably with peers, yet its valuation premium to Target and Albertsons is modest.
While acknowledging threats from Walmart and Amazon, Roth Capital concluded that Kroger “deserves re-rating higher as performance continues.”
You May Also Be Interested In
- Raymond James sees token pricing gap widen in August 2026
- Hinge Health signs $86M office lease in San Francisco
- loanDepot receives NYSE non-compliance notice over stock price
Create E-mail Alert Related Categories
General News, InvestingRelated Entities
Roth Capital, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share